Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

98
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
98
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

104
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
104
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

85
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
85
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

461
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucagon-Like Peptide-1 Receptor Agonists in Breast Cancer: Metabolic, Clinical, and Survivorship Implications.

JCO oncology practice·2026
Same author

Management of bone health in adult solid organ transplant recipients: a multidisciplinary care pathway.

Clinical transplantation and research·2026
Same author

Effect of Social Vulnerability on Efficacy of Bariatric Surgery Versus Medical and Lifestyle Intervention for Type 2 Diabetes: Analysis of the ARMMS-T2D Consortium of Randomized Trials.

Annals of internal medicine·2026
Same author

Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin Agonists.

The Journal of clinical endocrinology and metabolism·2025
Same author

Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.

Journal of diabetes science and technology·2025
Same author

Long-term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction-associated fatty liver disease in adults with obesity and type 2 diabetes.

Diabetes, obesity & metabolism·2024

Related Experiment Video

Updated: Oct 19, 2025

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.2K

Early Post-Renal Transplant Hyperglycemia.

Anira Iqbal1, Keren Zhou2, Sangeeta R Kashyap2

  • 1Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

The Journal of Clinical Endocrinology and Metabolism
|September 24, 2021
PubMed
Summary

Early post-renal transplant hyperglycemia (EPTH) increases risks for kidney transplant recipients, including infections and graft failure. Proactive screening and management are crucial for better outcomes.

Keywords:
earlyhyperglycemiaimmediaterenaltransienttransplant

More Related Videos

Surgical Tips and Tricks for Performing Porcine Pancreas Transplantation
10:32

Surgical Tips and Tricks for Performing Porcine Pancreas Transplantation

Published on: July 20, 2022

1.9K
Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

9.7K

Related Experiment Videos

Last Updated: Oct 19, 2025

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
17:13

Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET

Published on: April 28, 2013

17.2K
Surgical Tips and Tricks for Performing Porcine Pancreas Transplantation
10:32

Surgical Tips and Tricks for Performing Porcine Pancreas Transplantation

Published on: July 20, 2022

1.9K
Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

9.7K

Area of Science:

  • Nephrology
  • Endocrinology
  • Transplantation Medicine

Background:

  • Posttransplant diabetes mellitus (PTDM) is well-documented, but early post-renal transplant hyperglycemia (EPTH), occurring within 45 days, poses significant risks.
  • EPTH affects both patients with and without pre-existing diabetes, highlighting a critical post-transplant management gap.

Observation:

  • EPTH is linked to adverse outcomes such as acute graft failure, increased rehospitalizations, cardiovascular events, and infections like CMV and potentially COVID-19.
  • Risk factors for EPTH include elevated pretransplant glucose, pre-existing diabetes, glucocorticoid use, and posttransplant infections.

Findings:

  • Hyperglycemia after kidney transplant can lead to acute graft rejection and PTDM.
  • Insulin is the current standard for inpatient management, with close outpatient follow-up recommended.
  • Emerging treatments like DPP-4 inhibitors and GLP-1 receptor agonists show promise, but data on SGLT2 inhibitors is limited due to renal function concerns.

Implications:

  • Early recognition and proactive management of EPTH are essential to mitigate severe complications in kidney transplant recipients.
  • Further research is needed to evaluate non-insulin agents for EPTH to reduce hypoglycemia risks and long-term adverse effects.